1
Clinical Trials associated with Tumor lysate-loaded autologous dendritic cells(Erasmus MC)Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma
Exploiting the immunostimulatory capacities of dendritic cells holds great promise for cancer immunotherapy. A mouse model for malignant mesothelioma allowed us to prove that autologous dendritic cells presenting tumor antigens were very effective by (partly) inhibiting tumor growth. This study will test the feasibility and safety of a clinical trial using autologous DC as a therapeutic adjuvant for the treatment of malignant pleural mesothelioma.
100 Clinical Results associated with Tumor lysate-loaded autologous dendritic cells(Erasmus MC)
100 Translational Medicine associated with Tumor lysate-loaded autologous dendritic cells(Erasmus MC)
100 Patents (Medical) associated with Tumor lysate-loaded autologous dendritic cells(Erasmus MC)
100 Deals associated with Tumor lysate-loaded autologous dendritic cells(Erasmus MC)